✦ LIBER ✦

238Oral (PO) Valganciclovir (VGC) for preemptive therapy of Cytomegalovirus (CMV) Antigenemia (AG) in hematopoietic stem cell transplant (HSCT) recipients

✍ Scribed by H.L. Leather; C.L. Meyer; J.R. Wingard

Book ID: 117728228
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 141 KB
Volume: 9
Category: Article
ISSN: 1083-8791
DOI: 10.1016/s1083-8791(03)80223-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral valganciclovir as preemptive therap

Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

✍ Katsuto Takenaka; Tetsuya Eto; Koji Nagafuji; Kenjiro Kamezaki; Yayoi Matsuo; Go 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 215 KB

Initial low-dose valganciclovir as a pre

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

✍ Takenaka, Katsuto; Nagafuji, Koji; Takase, Ken; Kamimura, Tomohiko; Mori, Yasuo; 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 515 KB

Validation of a DNAemia cutoff for preem

Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

✍ Gerna, G; Lilleri, D; Caldera, D; Furione, M; Zenone Bragotti, L; Alessandrino, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Clinically-based determination of safe D

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients

✍ Daniele Lilleri; Fausto Baldanti; Marta Gatti; Francesca Rovida; Luca Dossena; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract Transplantation Centers using human cytomegalovirus (HCMV) antigenemia‐based preemptive therapy will need to replace in the near future the antigenemia assay with a more standardized and automatable assay, such as a molecular assay quantifying HCMV DNA in blood (DNAemia). Thus, in view